| 영문 | chronic lymphocytic leukemia | 한글 | 만성림프성 백혈병 |
|---|---|---|---|
| 설명 | 백혈병(leukemia)란 비정상적인 백혈구 세포의 증식에 의해 일어나는 병적인 상태를 말하는데, 흔히 말초혈액에 미분화세포가 나타나며, 정상적인 적혈구세포와 백혈구세포, 혈소판의 급격한 감소를 가져와 정상적인 세포에 의해 행해지는 여러 기능의 감소를 주증상으로 하여 병원에 찾아오게 된다. 따라서 적혈구세포의 감소로 인한 빈혈, 백혈구세포의 감소로 인한 많은 감염증세(흔히 걸리지 않는 세균에 의한 감염, 지나치게 잦은 감기, 폐렴 등), 혈소판세포의 감소로 인한 출혈증상이 나타난다. 또한 피를 생산하는 골수 조직에서는 이런 비정상적인 세포의 증식만을 볼 수 있으며, 정상적인 세포의 증식은 보기 힘들다. 만성림프성 백혈병은 서양에서는 비교적 백혈병 중에서 흔한 형이지만 동양권에서는 아주 드문 백혈병의 형태이다. 대개 60세 이상의 고령층에서 많이 생기고 30세 이하에서는 거의 찾아볼 수가 없다. 혈액검사상에서 림프구의 많은 증가를 볼 수가 있고, 대신에 다른 혈액세포들은 감소를 나타낸다. 백혈병 중 예후가 좋은 편이며 대개 치료는 항암제를 이용한 화학요법을 많이 사용하며, 평균 생존기간은 4~5년이다. |
||
| 영문 | leukemia | 한글 | 백혈병 |
|---|---|---|---|
| 설명 | 비정상적인 백혈구 세포의 증식에 의해 일어나는 병적인 상태를 말하는데, 흔히 말초 혈액에 미분화세포가 나타나며, 정상적인 적혈구세포와 백혈구세포, 혈소판의 급격한 감소를 가져와 정상적인 세포에 의해 행해지는 여러 기능의 감소를 주증상으로 하여 병원에 찾아오게 된다. 따라서 적혈구 세포의 감소로 인한 빈혈, 백혈구세포의 감소로 인한 많은 감염증세(흔히 걸리지 않는 세균에 의한 감염, 지나친 잦은 감기, 폐렴 등), 혈소판세포의 감소로 인한 출혈증상이 나타난다. 또한 피를 생산하는 골수 조직에서는 이런 비정상적인 세포의 증식만을 볼 수 있으며, 정상적인 세포의 증식은 보기 힘들다. 이런 백혈병에는 여러 가지가 있는 데 크게 4가지로 나누어 분류한다. 정상적으로 백혈구세포는 림프계세포와 골수계세포로 2분되는데, 백혈병 또한 이런 림프계세포의 증식과 골수계세포의 증식에 따라 나누며, 그 증상이 얼마나 빨리 나타나는 가에 따라 만성, 급성으로 나눈다. 따라서 여기에는 다음 4가지의 분류가 나오게 된다. -급성림프성 백혈병: acute lymphocytic -급성골수성 백혈병: acute myelogenous -만성림프성 백혈병: chronic lymphocytic -만성골수성 백혈병: chronic myelogenous. |
||
| AML | Acute Myelogenous Leukemia Morphologic Classification(FAB분류) &n... |
|---|---|
| MMM | see 3-M [syndrome]; microsome-mediated mutagenesis; myelofibrosis with myeloid metaplasia; myeloscle... |
| AML | acute monocytic leukemia; acute mucosal lesion; acute myeloblastic leukemia; acute myelocytic leukem... |
| ACML | atypical chronic myeloid leukemia |
| MCGN | mesangiocapillary glomerulonephritis; minimal change glomerulonephritis; mixed cryoglobulinemia with... |
| HL-60 | Human myeloid leukemia cells |
|---|---|
| t-AML | Therapy-related acute myeloid leukemia |
| CML BC | chronic myeloid leukemia in blast crisis |
| AML | Acute Myeloid Leukaemia |
| AMM | Agnogenic myeloid metaplasia |
acute monocytic leukemia
| leukemia | <haematology> An acute or chronic disease of unknown cause in man and other warm blooded animals that involves the blood forming organs, is characterised by an abnormal increase in the number of leucocytes in the tissues of the body with or without a corresponding increase of those in the circulating blood and is classified according of the type leucocyte most prominently involved. (18 Nov 1997) |
|---|---|
| acute myeloid leukaemia | <haematology> A rapidly progressing cancer of the blood affecting immature cells of the bone marrow, usually of the white cell population. It is much more common in adults than in children. Symptoms include fatigue, weight loss, fevers, weakness, pallor, bone pains, bleeding gums, nosebleeds, easy bruising, enlarged lymph nodes and joint pains. Treatment includes chemotherapy and/or bone marrow transplant. This leukaemia demonstrates granulocyte differentiation, eosinophilia and Auer rods and is associated with a reciprocal translocation between 8 and 21 (q22;q22), which is the most common translocation in acute myeloid leukaemia and is found more often in younger patients than in older patients. The oncogene involved in this translocation is AML1, which can be detected by Southern blot. Numerical abnormalities, particularly monosomy-7, trisomy-4, trisomy-8, trisomy-21, -Y, monosomy-7 and deletions of the long arms of chromosomes 5 and 7 are quite common in all acute myeloid leukaemia and not restricted to any one FAB classification. Many of these abnormalities are observed at diagnosis and at later stage disease, particularly after chemotherapy. Prognosis is generally more favorable than in FAB-M2 patients showing no translocation, because the latter patients show better remission rates for longer periods of time. Immunophenotyping is useful in diagnosis and expression of one or more of the myeloid antigens CD13, CD14 or CD33 must be detected to make a diagnosis of acute myeloid leukaemia. Acronym: AML Incidence: 2,000 new cases per year in the UK. Origin: Gr. Haima = blood (07 Apr 1998) |
| agnogenic myeloid metaplasia | A progressive disease of the bone marrow where neoplastic bone marrow stem cells lodge and grow in multiple sites outside the bone marrow. Typically, there is enlargement of the spleen and a gradual replacement of the bone marrow elements by fibrosis (scarring), progressive anaemia and variable changes in the number of white blood cells and platelets. Diagnosis is by bone marrow biopsy. There is no definitive treatment for this disorder that has been shown to affect life span favorably. Origin: Gr. Plassein = to form (27 Sep 1997) |
| chronic myeloid leukaemia | <haematology> A leukaemia which is initially slowly-progressing. There are approximately 650 new cases each year in the UK. It is characterised by the presence of large numbers of abnormal mature granulocytes, circulating in the blood. Synonym: chronic granulocytic leukaemia. Acronym: CML Origin: Gr. Haima = blood (12 Jan 1998) |
| myeloid | Collective term for the nonlymphocyte groups of white blood cells. It includes cells from the granulocyte, monocyte and platelet lineages. (13 Nov 1997) |
| myeloid cell | <haematology, pathology> One of the two classes of marrow derived blood cells, includes megakaryocytes, erythrocyte precursors, mononuclear phagocytes and all the polymorphonuclear granulocytes. That all these are ultimately derived from one stem cell lineage is shown by the occurrence of the Philadelphia chromosome in these, but not lymphoid, cells. most authors tend, however, to restrict the term myeloid to mononuclear phagocytes and granulocytes and commonly distinguish a separate erythroid lineage. (12 May 1997) |
| myeloid metaplasia | A progressive disease of the bone marrow where neoplastic bone marrow stem cells lodge and grow in multiple sites outside the bone marrow. Typically, there is enlargement of the spleen and a gradual replacement of the bone marrow elements by fibrosis (scarring), progressive anaemia and variable changes in the number of white blood cells and platelets. Diagnosis is by bone marrow biopsy. There is no definitive treatment for this disorder that has been shown to affect life span favorably. Origin: Gr. Plassein = to form (27 Sep 1997) |
| myeloid sarcoma | <tumour> A malignant tumour of immature myeloid cells, frequently subperiosteal, associated with or preceding granulocytic leukaemia. See: chloroma. Synonym: myeloid sarcoma. (05 Mar 2000) |
| myeloid series | The granulocytic and the erythrocytic series. (05 Mar 2000) |
| myeloid tissue | Bone marrow consisting of the developmental and adult stages of erythrocytes, granulocytes, and megakaryocytes in a stroma of reticular cells and fibres, with sinusoidal vascular channels. (05 Mar 2000) |
| primary myeloid metaplasia | Myeloid metaplasia occurring as the primary condition, often in association with myelofibrosis. Synonym: agnogenic myeloid metaplasia. (05 Mar 2000) |
| secondary myeloid metaplasia | Myeloid metaplasia occurring in individuals with another disease. Synonym: symptomatic myeloid metaplasia. (05 Mar 2000) |
| symptomatic myeloid metaplasia | Myeloid metaplasia occurring in individuals with another disease. Synonym: symptomatic myeloid metaplasia. (05 Mar 2000) |
| leukaemia, myeloid | Form of leukaemia characterised by an uncontrolled proliferation of the myeloid lineage and their precursors in the bone marrow and other sites. (12 Dec 1998) |
Synonyms : Granulocytic Leukemia, Chronic, Stable Phase, Leukemia, Granulocytic, Chronic Phase, Leukemia, Myelogenous, Chronic Phase, Leukemia, Myeloid, Chronic Phase, Leukemia, Myeloid, Stable Phase, Myelogenous Leukemia, Chronic, Chronic Phase
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|